This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Su Chong
Introduction
Su Chong is an accomplished inventor based in Oxnard, CA. He has made significant contributions to the field of peptide research, particularly in relation to PAC1 antagonists. His work is particularly relevant for the treatment and prevention of headache disorders, including migraines.
Latest Patents
Su Chong holds a patent for "Peptide PAC1 antagonists." This patent describes novel peptides that bind to human PAC1. These peptides serve as antagonists of PAC1 and are useful in addressing various PAC1-related disorders, including acute migraine.
Career Highlights
Su Chong is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on innovative solutions in the realm of peptide therapeutics. His expertise has led to advancements in understanding and treating headache disorders.
Collaborations
Su Chong collaborates with notable colleagues, including Irwin Chen and Leslie Phillip Miranda. Their combined efforts contribute to the ongoing research and development of effective treatments in their field.
Conclusion
Su Chong's contributions to peptide research and his innovative patent for PAC1 antagonists highlight his role as a significant inventor in the biotechnology sector. His work continues to pave the way for advancements in the treatment of migraine and other related disorders.